Nyström Petter K, Carlsson Axel C, Leander Karin, de Faire Ulf, Hellenius Mai-Lis, Gigante Bruna
Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Centre for Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
PLoS One. 2015 May 15;10(5):e0127111. doi: 10.1371/journal.pone.0127111. eCollection 2015.
We aimed to investigate whether different measures of obesity could similarly predict atrial fibrillation, and whether the atrial fibrillation risk associated with obesity is dependent on presence of metabolic syndrome.
We performed our study in a population-based longitudinal cardiovascular study, comprising 1 924 men and 2 097 women, aged 60 years, from Stockholm. Body mass index, waist circumference, sagittal abdominal diameter and components of metabolic syndrome (systolic- and diastolic blood pressure, fasting glucose, triglycerides, high-density lipoprotein-cholesterol) were recorded at baseline. Participants were classified by their body mass index (normal weight, overweight or obese), waist circumference (normal, semi-elevated or elevated), and according to presence of metabolic syndrome. Atrial fibrillation risk was estimated by Cox proportional hazards regression models, adjusted for common atrial fibrillation risk factors, expressed as HR and 95% CI.
During a mean follow-up of 13.6 years, 285 incident atrial fibrillation cases were recorded. One standard deviation increment of each obesity measure was associated with increased atrial fibrillation risk as: body mass index 1.25 (1.12 - 1.40), waist circumference 1.35 (1.19 - 1.54) and sagittal abdominal diameter 1.28 (1.14 - 1.44). Compared to normal weight subjects without metabolic syndrome, increased atrial fibrillation risk was noted for overweight subjects with metabolic syndrome, 1.67 (1.16 - 2.41), obese subjects without metabolic syndrome, 1.75 (1.11 - 2.74) and obese subjects with metabolic syndrome, 1.92 (1.34 - 2.74). Compared to subjects with normal waist circumference without metabolic syndrome, subjects with elevated waist circumference and metabolic syndrome suffered increased atrial fibrillation risk, 2.03 (1.44 - 2.87).
Body mass index, waist circumference and sagittal abdominal diameter could similarly predict atrial fibrillation. Obesity was associated with an increased atrial fibrillation risk regardless of metabolic syndrome, whereas overweight and elevated waist circumference was associated with increased atrial fibrillation risk only if metabolic syndrome was present.
我们旨在研究不同的肥胖测量指标是否能同样地预测房颤,以及与肥胖相关的房颤风险是否取决于代谢综合征的存在。
我们在一项基于人群的纵向心血管研究中开展了此项研究,该研究纳入了来自斯德哥尔摩的1924名男性和2097名60岁女性。在基线时记录体重指数、腰围、腹矢状径以及代谢综合征的组成成分(收缩压和舒张压、空腹血糖、甘油三酯、高密度脂蛋白胆固醇)。参与者根据其体重指数(正常体重、超重或肥胖)、腰围(正常、半升高或升高)以及代谢综合征的存在情况进行分类。通过Cox比例风险回归模型估计房颤风险,并针对常见的房颤风险因素进行调整,结果以风险比(HR)和95%置信区间(CI)表示。
在平均13.6年的随访期间,记录到285例新发房颤病例。每种肥胖测量指标增加一个标准差与房颤风险增加相关,具体如下:体重指数为1.25(1.12 - 1.40),腰围为1.35(1.19 - 1.54),腹矢状径为1.28(1.14 - 1.44)。与无代谢综合征的正常体重受试者相比,有代谢综合征的超重受试者房颤风险增加,为1.67(1.16 - 2.41),无代谢综合征的肥胖受试者为1.75(1.11 - 2.74),有代谢综合征的肥胖受试者为1.92(1.34 - 2.74)。与腰围正常且无代谢综合征的受试者相比,腰围升高且有代谢综合征的受试者房颤风险增加,为2.03(1.44 - 2.87)。
体重指数、腰围和腹矢状径都能同样地预测房颤。无论是否存在代谢综合征,肥胖都与房颤风险增加相关,而超重和腰围升高仅在存在代谢综合征时才与房颤风险增加相关。